See also this year's filing and all EDGAR filings for this company.
PDF Report 0001609809_2023_Seres_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001609809, Seres Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 194,764,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 22,985,000 |
| 3 | remainder_Assets | 131,035,000 |
| 4 | LiabilitiesCurrent | 85,596,000 |
| 5 | LiabilitiesNoncurrent | 109,384,000 |
| 6 | remainder_Liabilities | 143,021,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 79,694,000 |
| 9 | ResearchAndDevelopmentExpense | 172,920,000 |
| 10 | remainder_Expenses | 1,004,000 |
| 11 | remainder_Revenues | 7,128,000 |
| 12 | remainder_NetIncome | -3,667,000 |
| 13 | remainder_ComprehensiveNetIncome | 48,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 348,784,000 |
| 1 | Liabilities | 338,001,000 |
| 2 | Expenses | 253,618,000 |
| 3 | Revenues | 7,128,000 |
| 4 | StockholdersEquity | 10,783,000 |
| 5 | NetIncome | -250,157,000 |
| 6 | ComprehensiveNetIncome | -250,133,000 |
| 7 | BaseVar | 475,623,000 |
| 8 | EconomicCapitalRatio | -0.674 |
Edgar->Model Mapping
Feature Distribution
Change over Time
